, , , . , . , . 24-48 .
. - N.gonorrhoeae (QRNG) T , . (Centers for Disease Control) (CDC) (. ).
CDC 2006 ( 2007), (DGI) : 1 \ \ 24 (12, ), 1 \ 8, 1 \ 8.
CDC 2007 , . (Gonococcal Isolate Surveillance Project) (GISP) CDC, , (QRNG) 6.7 %, 11 0.6 % 2001. (eg, ceftriaxone 125 \ ). DGI, . , . - CDC; CDC ( 2007); Medscape DC - (CDC's Antibiotic-Resistant Gonorrhea Web site; CDC's Updated gonococcal treatment recommendations (April 2007); or Medscape Medical News on CDC Issues - New Treatment Recommendations for Gonorrhea).
DGI , , . ciprofloxacin (400 \ 12; 400 bid), ofloxacin (400 \ 12), levofloxacin (250 /d \; 500 /d ), spectinomycin (2 \ 12). , 24-48 , :
|
|
Cefixime 400 mg ( )
Cefixime 500 mg
Cefpodoxime 400 mg
1 .
(< 8 ). . . Spectinomycin , . 50\/d \ \ 7 . , DGI .
DGI . (4-6 ), .
, . , . .
30-50 % Chlamydia, azithromycin (1 ) doxycycline (100 7 ). erythromycin (500 qid 7 ) amoxicillin (500 tid 7). :
, 45 - Erythromycin- ethylsuccinate 50 / qid 14
, 45 , 8 - Azithromycin 1
8 - Azithromycin 1 doxycycline 100 7